Company intelligence / Profile preview

Global Tech Opportunities 13

Ownership: Private
Development stage: Other

Overview

Global Tech Opportunities 13 is a financing vehicle belonging to the Alpha Blue Ocean group that provides structured, often convertible, financing (e.g., OCEANE-BSA convertible bonds and loans) to listed companies such as Pharnext and Neovacs; it is not itself a life science/biotech company but an investor and financing counterparty.[1][2][5][7]

Industry: Investors

Partnerships

PharnextNeovacs

Beyond the preview

Go deeper on Global Tech Opportunities 13.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Tech Opportunities 13.

Explore the full profile